Transforming Drug Therapy with Deep Learning: The Future of Personalized Medicine
Drug Research · 2025-10 · 75 (08) · 326-333
DOI: 10.1055/a-2682-5167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, online erschienen am 29.08.2025. Verfasst von Altaf Osman Mulani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electronics and Telecommunication, SKN Sinhgad College of Engineering, Pandharpur, Maharashtra, India. Hauptthemen laut MEDLINE: Precision Medicine, Deep Learning. Die Arbeit wurde bisher 144-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Personalized medicine represents a paradigm shift in healthcare, aiming to tailor treatment strategies to the unique genetic, environmental, and lifestyle characteristics of individual patients. This approach holds immense potential for improving therapeutic efficacy and minimizing adverse drug reactions. With the rapid advancement of artificial intelligence, deep learning has emerged as a transformative tool in pharmacology, enabling precise modeling of complex biological data and uncovering hidden patterns in patient-specific information. This study investigates the application of deep learning techniques – such as Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Transformer architectures, and Generative Adversarial Networks (GANs) – in optimizing personalized treatment strategies. Using a diverse dataset comprising electronic health records (EHRs), genomic sequences, and clinical indicators, we developed and trained deep learning models for tasks including drug response prediction, biomarker identification, and adverse drug reaction (ADR) forecasting. Among the models evaluated, Transformer-based architectures demonstrated superior performance, achieving an accuracy of 91.2% and an AUC-ROC of 0.92 in drug response prediction tasks. Moreover, the integration of deep learning models into the treatment pipeline resulted in a 20–30% improvement in drug-patient matching efficiency compared to traditional statistical methods. The findings underscore the potential of AI-powered systems to enhance clinical decision-making and enable precision pharmacotherapy. However, challenges such as data privacy, model interpretability, and regulatory compliance remain critical barriers to widespread adoption. The study also explores future directions, including the implementation of explainable AI (XAI) and federated learning, to address these limitations and facilitate the integration of deep learning into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Electronics and Telecommunication, SKN Sinhgad College of Engineering, Pandharpur, Maharashtra, India.
- Department of Electronics and Telecommunication, Vishwakarma Institute of Technology, Pune, India.
- Department of Computer Engineering, Ramrao Adik Institute of Technology, D. Y. Patil University, Navi Mumbai, India.
- Department of Electronics and Telecommunication, Bharati Vidyapeeth's College of Engineering for Women, Pune, India.
- School of Engineering (EEE), SR University, Warangal, Telangana, India.
Zitieren
APA
Mulani, A. O., Deshmukh, M., Jadhav, V., Chaudhari, K., Mathew, A. A., & Salunkhe, S. (2025). Transforming Drug Therapy with Deep Learning: The Future of Personalized Medicine. Drug Research, 75(08), 326-333. https://doi.org/10.1055/a-2682-5167
Vancouver
Mulani AO, Deshmukh M, Jadhav V, Chaudhari K, Mathew AA, Salunkhe S. Transforming Drug Therapy with Deep Learning: The Future of Personalized Medicine. Drug Research. 2025;75(08):326-333. doi:10.1055/a-2682-5167
BibTeX
@article{Mulani2025,
author = {Mulani, Altaf Osman and Deshmukh, Minal and Jadhav, Vaishali and Chaudhari, Kalyani and Mathew, Ammu Anna and Salunkhe, Shweta},
title = {Transforming Drug Therapy with Deep Learning: The Future of Personalized Medicine},
journal = {Drug Research},
year = {2025},
volume = {75},
number = {08},
pages = {326--333},
doi = {10.1055/a-2682-5167}
}
EUVIMED